CD133 correlated with levels of AKT serine/threonine kinase (AKT) and BCL2 apoptosis regulator (BCL2), and increased tumor propagation potential, corresponding with its role in cell stemness [154]. This evidence concerns the gene BCL2 and neoplasm.